Viewing nowAtorjal 10 mg Tablet (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
SaeHan Pharmaceutical Co., Ltd.

MFDS item code 201904207 · Approved 2019.06.17 · Insurance code 651300710
Improvement of hyperlipidemia (including in children); prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps lower the risk of cardiovascular diseases. In particular, it reduces the risk of myocardial infarction and stroke in adults with multiple risk factors or patients with type 2 diabetes. Additionally, it is effective in reducing the risks of myocardial infarction, stroke, vascular surgery, hospitalization due to congestive heart failure, and angina in patients with clinically confirmed coronary heart disease. This drug also lowers total cholesterol, LDL cholesterol, apolipoprotein B, and triglyceride levels while increasing HDL cholesterol levels in the treatment of hyperlipidemia. It is particularly used in patients with familial hypercholesterolemia or patients with dyslipidemia who do not respond to diet. This drug is also used to control cholesterol levels in pediatric patients with familial hypercholesterolemia who meet specific criteria. In summary, this drug effectively reduces various risks of cardiovascular diseases and treats different forms of hyperlipidemia and familial hypercholesterolemia.
Patients taking atorvastatin, before and during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring greater LDL cholesterol reduction may start at 20 mg or 40 mg once daily (only when an LDL cholesterol reduction of 45 % or more is required). This medicine is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia: This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. Elderly patients: Efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administration of doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted at intervals of 4 weeks or longer.
This medication should be discontinued immediately if any abnormal muscle symptoms occur, and particularly if severe muscle pain or weakness is present, consultation with a doctor is necessary. This drug should not be used in patients with specific liver diseases or severely impaired liver function. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraceptive methods while taking it. This drug should not be administered to children, especially those under 10 years of age. Patients with liver or kidney function problems should use this medication with caution, and regular check-ups are recommended. Drug interactions may occur when taking this medication with other drugs, so it is essential to inform the doctor or pharmacist if any other medications are currently being taken. This drug may cause allergic reactions or severe skin rashes, so if any abnormal symptoms occur, stop taking it immediately and consult a doctor. In cases of overdose, there is no specific antidote, so seek medical attention immediately for treatment based on symptoms. When storing, keep it out of reach of children and store in its original container to maintain the drug's quality. Elderly patients or those with a history of muscle disorders are at higher risk for muscle-related side effects and should be particularly cautious when taking this medication.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to prevent exposure to air and moisture. The recommended storage temperature is between 1 degree and 30 degrees Celsius at room temperature.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
SaeHan Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.